Rankings
▼
Calendar
TLSI Q2 2021 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
TLSI
TriSalus Life Sciences, Inc.
$175M
Q2 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$783,925
Net Income
$378,866
EPS (Diluted)
$0.01
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$486,206
Free Cash Flow
-$486,210
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$251M
Total Liabilities
$23M
Stockholders' Equity
$229M
Cash & Equivalents
$642,944
← FY 2021
All Quarters
Q3 2021 →
